Screening all US adults aged 35 and older for chronic kidney disease could be cost-effective
A cost-effectiveness analysis of screening for chronic kidney disease (CKD) has found that screening all adults in the United States starting at age 35 could be cost-effective for the quality of life-years (QALY) gained. ...
May 22, 2023
0
2